Literature DB >> 17348751

Retinoblastoma--a clinico-pathological study in Ilorin, Nigeria.

Joshua F A Owoeye1, Enoch A O Afolayan, Dupe S Ademola-Popoola.   

Abstract

Retinoblastoma is the commonest childhood primary malignant intraocular neoplasm that is often characterized by spontaneous regression. They display photoreceptor differentiation. This study provides the clinical presentations and histological profiles of retinoblastoma in Ilorin, Kwara-State, in the North Central geo-political zone of Nigeria. A retrospective study of clinically and histologically verified retinoblastoma at the University of Ilorin Teaching Hospital, Ilorin, Kwara-State, Nigeria from January 1989 to December 2000 was undertaken. The clinical and histological features were analyzed using the patient's case folder and surgical pathology records. There were 20 patients, 9 males and 11 females (M:F ratio 1: 1.2), age range from 5 (1/2) months to 6 years with 23 eyeball tumours histologically confirmed retinoblastoma during the study period. Proptosis with chemosis was the most common clinical presentation (84.6 %). Bilaterality was 15 % in this study. Enucleation and Exenteration combined with chemotherapy were offered to 15 (75 %) and 5 (25 %) patients respectively. A poorly differentiated type with extensive areas of tumour necrosis was the commonest histological pattern. Thirteen (65 %) of the patients died before completing the course of chemotherapy.

Entities:  

Mesh:

Year:  2006        PMID: 17348751     DOI: 10.4314/ajhs.v13i1.30825

Source DB:  PubMed          Journal:  Afr J Health Sci        ISSN: 1022-9272


  11 in total

1.  Clinical presentation and outcome of retinoblastoma based on age at presentation: a review of 1450 children.

Authors:  Swathi Kaliki; Arpita Maniar; Anamika Patel; Vijay Anand Reddy Palkonda; Ashik Mohamed
Journal:  Int Ophthalmol       Date:  2019-08-23       Impact factor: 2.031

2.  Characteristics and clinical presentations of pediatric retinoblastoma in North-western Iran.

Authors:  Reza Nabie; Nazli Taheri; Ali Mahdavi Fard; Rohollah Fadaei Fouladi
Journal:  Int J Ophthalmol       Date:  2012-08-18       Impact factor: 1.779

3.  Clinical presentation of retinoblastoma in Malaysia: a review of 64 patients.

Authors:  S C Reddy; S Anusya
Journal:  Int J Ophthalmol       Date:  2010-03-18       Impact factor: 1.779

4.  [Retinoblastoma in Kenya: survival and prognostic factors].

Authors:  E N Gichigo; M M Kariuki-Wanyoike; K Kimani; M M Nentwich
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

5.  High-Risk Histopathologic Features of Retinoblastoma Treated at a Tertiary Hospital in West Java, Indonesia.

Authors:  Nur Melani Sari; Regina Hadiputri; Maya Sari Kuntorini; Hasrayati Agustina; Friska Mardianty
Journal:  Ocul Oncol Pathol       Date:  2021-07-20

6.  Retinoblastoma in the democratic republic of congo: 20-year review from a tertiary hospital in kinshasa.

Authors:  Aimé Kazadi Lukusa; Michel Ntetani Aloni; Bertin Kadima-Tshimanga; Moïse Mvitu-Muaka; Jean Lambert Gini Ehungu; René Ngiyulu; Pépé Ekulu Mfutu; Aléine Budiongo Nzazi
Journal:  J Cancer Epidemiol       Date:  2012-04-26

7.  Awareness and knowledge of ocular cancers in a resource-limited economy.

Authors:  Abdulkabir A Ayanniyi; Abubakar M Jamda; Kabir B Badmos; Rabi S Adelaiye; Abdulraheem O Mahmoud; Fatima Kyari; Edmund J Nwana
Journal:  N Am J Med Sci       Date:  2010-11

8.  Clinicopathologic presentation of malignant orbito-ocular tumors in Kano, Nigeria: A prospective multicenter study.

Authors:  Saudat Garba Habib; Abdu Lawan; Pam Victoria
Journal:  Ann Afr Med       Date:  2019 Apr-Jun

9.  Clinicopathological Findings of Retinoblastoma: A 10-Year Experience from a Tertiary Hospital in Kampala, Uganda.

Authors:  James Joseph Yahaya; Belson Rugwizangoga; Alex Mremi; Asafu Munema
Journal:  J Ophthalmol       Date:  2019-06-16       Impact factor: 1.909

10.  Retinoblastoma in Mongolia: Clinical characteristics and survival from 1987 to 2014.

Authors:  Tsengelmaa Chuluunbat; Baasankhuu Jamiyanjav; Baylag Munkhuu; Uranchimeg Bazarsad; Altankhuu Molom; Ling-Yuh Kao; Wei-Chi Wu
Journal:  Taiwan J Ophthalmol       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.